302 related articles for article (PubMed ID: 38385079)
1. The Role of TGF-β/SMAD Signaling in Hepatocellular Carcinoma: from Mechanism to Therapy and Prognosis.
Xin X; Cheng X; Zeng F; Xu Q; Hou L
Int J Biol Sci; 2024; 20(4):1436-1451. PubMed ID: 38385079
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-181a-5p suppresses cell proliferation by targeting Egr1 and inhibiting Egr1/TGF-β/Smad pathway in hepatocellular carcinoma.
Bi JG; Zheng JF; Li Q; Bao SY; Yu XF; Xu P; Liao CX
Int J Biochem Cell Biol; 2019 Jan; 106():107-116. PubMed ID: 30503931
[TBL] [Abstract][Full Text] [Related]
3. miR-494 induces EndMT and promotes the development of HCC (Hepatocellular Carcinoma) by targeting SIRT3/TGF-β/SMAD signaling pathway.
Zhang J; Zhu Y; Hu L; Yan F; Chen J
Sci Rep; 2019 May; 9(1):7213. PubMed ID: 31076630
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of TGF-β/Smad signaling dependent cytostasis in human hepatocellular carcinoma cell lines.
Dzieran J; Fabian J; Feng T; Coulouarn C; Ilkavets I; Kyselova A; Breuhahn K; Dooley S; Meindl-Beinker NM
PLoS One; 2013; 8(8):e72252. PubMed ID: 23991075
[TBL] [Abstract][Full Text] [Related]
5. The repressive effect of miR-148a on TGF beta-SMADs signal pathway is involved in the glabridin-induced inhibition of the cancer stem cells-like properties in hepatocellular carcinoma cells.
Jiang F; Mu J; Wang X; Ye X; Si L; Ning S; Li Z; Li Y
PLoS One; 2014; 9(5):e96698. PubMed ID: 24806207
[TBL] [Abstract][Full Text] [Related]
6. Autocrine stimulatory mechanism by transforming growth factor beta in human hepatocellular carcinoma.
Matsuzaki K; Date M; Furukawa F; Tahashi Y; Matsushita M; Sakitani K; Yamashiki N; Seki T; Saito H; Nishizawa M; Fujisawa J; Inoue K
Cancer Res; 2000 Mar; 60(5):1394-402. PubMed ID: 10728705
[TBL] [Abstract][Full Text] [Related]
7. TGF-β signaling is often attenuated during hepatotumorigenesis, but is retained for the malignancy of hepatocellular carcinoma cells.
Mu X; Lin S; Yang J; Chen C; Chen Y; Herzig MC; Washburn K; Halff GA; Walter CA; Sun B; Sun LZ
PLoS One; 2013; 8(5):e63436. PubMed ID: 23704908
[TBL] [Abstract][Full Text] [Related]
8. Galangin suppresses HepG2 cell proliferation by activating the TGF-β receptor/Smad pathway.
Wang Y; Wu J; Lin B; Li X; Zhang H; Ding H; Chen X; Lan L; Luo H
Toxicology; 2014 Dec; 326():9-17. PubMed ID: 25268046
[TBL] [Abstract][Full Text] [Related]
9. Systematic Analysis of Cytostatic TGF-Beta Response in Mesenchymal-Like Hepatocellular Carcinoma Cell Lines.
Gungor MZ; Uysal M; Ozturk M; Senturk S
J Gastrointest Cancer; 2021 Dec; 52(4):1320-1335. PubMed ID: 34463913
[TBL] [Abstract][Full Text] [Related]
10. Contextual Regulation of TGF-β Signaling in Liver Cancer.
Tu S; Huang W; Huang C; Luo Z; Yan X
Cells; 2019 Oct; 8(10):. PubMed ID: 31614569
[TBL] [Abstract][Full Text] [Related]
11. Role of transforming growth factor-beta1-smad signal transduction pathway in patients with hepatocellular carcinoma.
Ji GZ; Wang XH; Miao L; Liu Z; Zhang P; Zhang FM; Yang JB
World J Gastroenterol; 2006 Jan; 12(4):644-8. PubMed ID: 16489684
[TBL] [Abstract][Full Text] [Related]
12. Reduced expression of transcriptional intermediary factor 1 gamma promotes metastasis and indicates poor prognosis of hepatocellular carcinoma.
Ding ZY; Jin GN; Wang W; Chen WX; Wu YH; Ai X; Chen L; Zhang WG; Liang HF; Laurence A; Zhang MZ; Datta PK; Zhang B; Chen XP
Hepatology; 2014 Nov; 60(5):1620-36. PubMed ID: 24954480
[TBL] [Abstract][Full Text] [Related]
13. Compound Astragalus and Salvia miltiorrhiza extracts suppress hepatocarcinogenesis by modulating transforming growth factor-β/Smad signaling.
Hu X; Rui W; Wu C; He S; Jiang J; Zhang X; Yang Y
J Gastroenterol Hepatol; 2014 Jun; 29(6):1284-91. PubMed ID: 24329763
[TBL] [Abstract][Full Text] [Related]
14. Sanguinarine inhibits epithelial-mesenchymal transition via targeting HIF-1α/TGF-β feed-forward loop in hepatocellular carcinoma.
Su Q; Fan M; Wang J; Ullah A; Ghauri MA; Dai B; Zhan Y; Zhang D; Zhang Y
Cell Death Dis; 2019 Dec; 10(12):939. PubMed ID: 31819036
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-β signaling in hepatocytes promotes hepatic fibrosis and carcinogenesis in mice with hepatocyte-specific deletion of TAK1.
Yang L; Inokuchi S; Roh YS; Song J; Loomba R; Park EJ; Seki E
Gastroenterology; 2013 May; 144(5):1042-1054.e4. PubMed ID: 23391818
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Genomes and Transcriptomes of Hepatocellular Carcinomas Identifies Mutations and Gene Expression Changes in the Transforming Growth Factor-β Pathway.
Chen J; Zaidi S; Rao S; Chen JS; Phan L; Farci P; Su X; Shetty K; White J; Zamboni F; Wu X; Rashid A; Pattabiraman N; Mazumder R; Horvath A; Wu RC; Li S; Xiao C; Deng CX; Wheeler DA; Mishra B; Akbani R; Mishra L
Gastroenterology; 2018 Jan; 154(1):195-210. PubMed ID: 28918914
[TBL] [Abstract][Full Text] [Related]
17. Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment.
Chen L; Yang T; Lu DW; Zhao H; Feng YL; Chen H; Chen DQ; Vaziri ND; Zhao YY
Biomed Pharmacother; 2018 May; 101():670-681. PubMed ID: 29518614
[TBL] [Abstract][Full Text] [Related]
18. Regulatory mechanisms for transforming growth factor beta as an autocrine inhibitor in human hepatocellular carcinoma: implications for roles of smads in its growth.
Matsuzaki K; Date M; Furukawa F; Tahashi Y; Matsushita M; Sugano Y; Yamashiki N; Nakagawa T; Seki T; Nishizawa M; Fujisawa J; Inoue K
Hepatology; 2000 Aug; 32(2):218-27. PubMed ID: 10915727
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of miR-23a approximately 27a approximately 24 decreases transforming growth factor-beta-induced tumor-suppressive activities in human hepatocellular carcinoma cells.
Huang S; He X; Ding J; Liang L; Zhao Y; Zhang Z; Yao X; Pan Z; Zhang P; Li J; Wan D; Gu J
Int J Cancer; 2008 Aug; 123(4):972-8. PubMed ID: 18508316
[TBL] [Abstract][Full Text] [Related]
20. Interferon-α2b and transforming growth factor-β1 treatments on HCC cell lines: Are Wnt/β-catenin pathway and Smads signaling connected in hepatocellular carcinoma?
Ceballos MP; Parody JP; Alvarez Mde L; Ingaramo PI; Carnovale CE; Carrillo MC
Biochem Pharmacol; 2011 Dec; 82(11):1682-91. PubMed ID: 21843516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]